Dr. Kiersten P Mullis, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 439 Us Hwy 158 West, Yanceville, NC 27379 Phone: 336-694-9331 |
News Archive
Mazor Robotics Ltd., the developer of Renaissanceā¢, an innovative surgical guidance system and its complementary products, announced today that it will be included in both the Tel Aviv Stock Exchange (TASE) Top 75 Index (TA-75) and Top 100 Index (TA-100), effective December 15, 2013.
Toll-like receptors are the guard dogs of the immune system, sniffing out bacteria and viruses then activating the body's immune system for an attack on these invaders.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
A team of researchers has come out with the first detailed map of the transcriptome and epitranscriptome of the virulent SARS-CoV-2 that causes COVID-19 disease, the illness that has become a pandemic ravaging both developed and less developed countries of the world. The study, published in the journal Cell in April 2020, may assist in the development of new vaccines and therapeutics.
The radiation oncology team at UH Seidman Cancer Center at UH Geauga Medical Center performed the first-ever prostate cancer treatment on April 3 using a newly approved device. The device, called SpaceOAR System, enhances the efficacy of radiation treatment by protecting organs surrounding the prostate. The device, a temporary injectable gel, received FDA clearance on April 1.
› Verified 3 days ago